Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.

Prostate cancer and prostatic diseases - 1 Jan 2004

Kakinuma H, Tsuchiya N, Habuchi T, Ohyama C, Matsuura S, Wang L, Nakamura A, Kato T

Abstract excerpt

Polymorphism of the steroid hormone-related genes might affect life-long androgen exposure, thus altering a risk of prostate cancer incidence. To evaluate the effect of the polymorphisms of CYP17 and SRD5A2 on serum steroid hormone levels, the 164 male Japanese cohort were tested for serum hormone levels and the genotype of the polymorphisms of CYP17 (T-C base substitution in the promoter region) and SRD5A2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Share to Androgens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Androstenedione

Share to DNA, Neoplasm

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Share to Testosterone

Source

Identifiers

PMID: 15477877
DOI: 10.1038/sj.pcan.4500753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.PMID 15477877Read ↗

Genetic polymorphism in sex hormone metabolism and prostate cancer risk.Semantic proximity Read ↗

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.Semantic proximity Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.Semantic proximity Read ↗

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).Semantic proximity Read ↗

Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.Semantic proximity Read ↗

Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population.Semantic proximity Read ↗

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Variant in sex hormone-binding globulin gene and the risk of prostate cancer.Semantic proximity Read ↗

Relationship between CYP17 gene polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.